University of Illinois at Chicago
Exemption #JDR428
Announcement of an Exempt Purchase
Award Info Published Thursday January 9, 2025
Amerisource Receivables Financial Corporation dba ASD Specialty Healthcare LLC/ASD HealthcareFrisco, TX
- Amount: An estimated $240,000
- Terms: An estimated start date of 1/25/2025 through 6/30/2026
- Renewals: None
Summary
Vendors
1 total
0 BEP vendors
0 VBP vendors
0 Small businesses
The University award process may be delayed as this award goes through a state approval process.
First published Thursday, January 9, 2025
The University awarded a contract for Arikayce.
This purchase is for Arikayce, an Orphan Drug with Limited Population status, for patients with MAC lung disease (Mycobacterium Avium Complex) who have limited or no alternative treatment options.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical at a university-operated health care center or dispensary that provides care, treatment, and medications for students, faculty and staff (30 ILCS 500 / 1-13(b-5)) This medication is used to treat a patient with MAC lung disease with no other options.
For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
The State of Illinois has a policy to encourage prospective vendors to hire qualified veterans, minorities, females, persons with disabilities and ex-offenders.